Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of paclitaxel-related neurological side effects with lithium
DRKS00027165Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Apr 2022
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in breast cancer and polyneuropathy comparing Lithium carbonate + paclitaxel with Placebo + paclitaxel (2 arms). Started Apr 2022; status: completed.
02
Drugs
lithium carbonate
03
Conditions
breast cancerpolyneuropathy
Beyond the preview
Go deeper on DRKS00027165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00027165.